It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols, resource allocation and drafting the right healthcare policies.
Henry Schein Inc. said it was withdrawing its financial guidance provided in February, citing the growing impact of the coronavirus pandemic on its business. The health care products and services com
Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at G.Research dropped their FY2020 EPS estimates for Henry Schein in a note issued to investors on Tuesday, March 31st. G.Research analyst K. Kedra
Henry Schein, Inc. (NASDAQ:HSIC), which is in the healthcare business, and is based in United States, received a lot...
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lowered its position in Henry Schein, Inc. (NASDAQ:HSIC) by 14.2% in the 4th quarter, HoldingsChannel.com reports. The institutional
Advisors Asset Management Inc. increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 157.2% in the 4th quarter, HoldingsChannel reports. The firm owned 6,194 shares of the company’s s
A Citigroup report argues that mass antibody testing can quickly locate millions of Americans with immunity to Covid-19. There are snags: Who will provide the tests, are they accurate, and does infect
XpresSpa pursues COVID-19 screening, testing at U.S. airports XSPA DGX AYTU HSIC
Cubist Systematic Strategies LLC bought a new position in Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commissio
Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at G.Research dropped their FY2022 EPS estimates for shares of Henry Schein in a research report issued on Tuesday, March 31st. G.Research analys
Un análisis de sangre rápido podría ayudarte a averiguar si has desarrollado anticuerpos para el nuevo coronavirus, lo que implica que ya lo has tenido.
Exact Sciences (NASDAQ:EXAS) initiated with an Outperform rating and a $70 (25% upside) price target at Evercore ISI.Health Catalyst (NASDAQ:HCAT) initiated with a Buy rating and a $40 (47% upside) pr
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE